1.Antibacterial Effect of Tea Tree Ingredient for Denture Cleaners.
Yu Ri CHOI ; Sung Suk BAE ; Min Kyung KANG
Journal of Dental Hygiene Science 2016;16(6):409-414
The purpose of this study was to evaluate the antibacterial effect of tea tree oil in denture cleaners. A self-curing denture resin was used to make the experimental specimen (12 mm×2 mm). A saline solution was used as the control. To observe surface changes after cleaning, the microhardness and color of the experimental specimen's surface were analyzed. For the antibacterial activity test, Candida albicans was used. The microhardness and color of the surface remained unchanged after cleaning. The result of the antibacterial activity test revealed that the tea tree oil-containing solutions had a more enhanced antibacterial effect than did the saline solution. Therefore, these results suggest that the tea tree oil-containing solution is a promising denture cleaners.
Candida albicans
;
Dentures*
;
Sodium Chloride
;
Tea Tree Oil
;
Tea*
;
Trees*
2.Xanthogranulomatous Appendicitis Mimicking Residual Burkitt's Lymphoma After Chemotherapy.
Soomin NAM ; Jeonghyun KANG ; Sung Eun CHOI ; Yu Ri KIM ; Seung Hyuk BAIK ; Seung Kook SOHN
Annals of Coloproctology 2016;32(2):83-86
The case of a 23-year-old female treated with aggressive high-dose therapy for Burkitt's lymphoma is reported. A positron emission tomography and computed tomography scan after completion of chemotherapy revealed a residual hypermetabolic lesion in the right pelvic cavity. A pelvic magnetic resonance imaging scan showed circumferential wall thickening at the tip of the appendix. A laparoscopic exploration and appendectomy were performed, and a pathologic examination of the resected appendix revealed xanthogranulomatous appendicitis. This is a rare case of a xanthogranulomatous appendicitis mimicking remnant Burkitt's lymphoma after completion of chemotherapy.
Appendectomy
;
Appendicitis*
;
Appendix
;
Burkitt Lymphoma*
;
Drug Therapy*
;
Female
;
Humans
;
Magnetic Resonance Imaging
;
Positron-Emission Tomography
;
Young Adult
3.Pseudohypoparathyroidism Presented With Seizure.
Minho HWANG ; Yu Ri JEONG ; Kyusik KANG ; Jong Moo PARK ; Ohyun KWON ; Byung Kun KIM ; JungJu LEE
Journal of the Korean Neurological Association 2011;29(2):133-135
Pseudohypoparathyroidism (PHP) is a rare clinical syndrome characterized by hypocalcemia, hyperphosphatemia and increase of serum parathyroid hormone in association with unique clinical features. We recently experienced a typical PHP type Ia patient who presented with recurrent seizure and muscle spasms and electroencephalogram (EEG) showed generalized spike-and-wave discharges. With the correction of hypocalcemia, seizures did not recur and epileptiform discharges disappeared. We suggest that the possibility of PHP should be considered in patients with seizures showing hypocalcemia and hyperphosphatemia.
Electroencephalography
;
Humans
;
Hyperphosphatemia
;
Hypocalcemia
;
Parathyroid Hormone
;
Pseudohypoparathyroidism
;
Seizures
;
Spasm
4.A primer on laryngeal dysfunction: Definition and diagnostic procedure
Yu Ri KANG ; Ji-Yoon OH ; Youngsang YOO ; Ji‑Hyang LEE ; Woo‑Jung SONG
Allergy, Asthma & Respiratory Disease 2024;12(2):48-57
Laryngeal dysfunction, previously referred to as vocal cord dysfunction or paradoxical vocal cord movement, is characterized by inappropriate, transient, and reversible narrowing of the larynx in response to external triggers, without any structural or neurological defects. This condition can manifest in various clinical ways and can be mistaken for other respiratory diseases, such as asthma. It is crucial to accurately recognize and diagnose laryngeal dysfunction to ensure the provision of appropriate treatment. Laryngoscopy with provocation, which is a standard tool for the diagnosis of laryngeal dysfunction, has been designated as a new medical technology in Korea in July 2022. In this review, we discuss the concept, epidemiology, diagnosis, and treatment of laryngeal dysfunction as well as introduce the diagnostic procedure using laryngoscopy with provocation.
5.Effect of the Short-Term Treatment of Paroxetine on Psychological States in Panic Disorder.
So Young LEE ; Ji Hae KIM ; Youl Ri KIM ; Eun Ho KANG ; Dong Soo LEE ; Bum Hee YU
Journal of Korean Neuropsychiatric Association 2004;43(3):312-319
OBJECTIVES: This study was designed to evaluate clinical effect of paroxetine treatment and to explore psychological predictors of treatment response. METHODS: Patients (n=26) who met DSM-IV criteria for panic disorder with or without agoraphobia were treated by paroxetine for 12 weeks. We assessed symptom improvement using Clinical Global Impression (CGI), and clinical characteristics using Anxiety Sensitivity Index (ASI), Anxious Thoughts and Tendencies (AT & T), Agoraphobic Cognition Questionnaire (ACQ), Body Sensation Questionnaire (BSQ), Beck Anxiety Inventory (BAI), and Beck Depression Inventory (BDI). T-test, correlation analysis, and stepwise multiple regression analysis were performed. RESULTS: Panic patients showed significant improvement in severity of illness and each clinical characteristic after 12 weeks of paroxetine treatment. There were significant correlations among severity of illness, anxiety, and depression, and subjective severity was related with catastrophic thoughts. The more catastrophic thoughts and the higher sensitivity of body sensation, Patients had the worse symptom improvement they shorved. Multiple regression analysis showed that catastrophic thought related to agoraphobia was the best predictor of symptom improvement (22%). CONCLUSION: This study suggests that short-term treatment of paroxetine is effective in panic disorder with or without agoraphobia, and that catastrophic thought could be a predictor of poor treatment response. Thus cognitive intervention on catastrohic thoughts may play an important role in symptom improvement in panic disorder.
Agoraphobia
;
Anxiety
;
Cognition
;
Depression
;
Diagnostic and Statistical Manual of Mental Disorders
;
Humans
;
Panic Disorder*
;
Panic*
;
Paroxetine*
;
Surveys and Questionnaires
;
Sensation
6.Interictal Gastric Motility in Patients with Migraine.
Yu Ri JEONG ; Minho HWANG ; Kyusik KANG ; Ohyun KWON ; Jong Moo PARK ; JungJu LEE ; Yunju JO ; Byung Kun KIM
Journal of the Korean Neurological Association 2011;29(4):291-294
BACKGROUND: Nausea and vomiting are predominant accompanying symptoms of migraine attacks. Although the underlying mechanism is not yet clear, gastric stasis is assumed to be the main factor. However, few studies have used direct methods to establish delayed gastric emptying of migraine patients. We compared interictal gastric motility between migraine patients and normal controls with the aid of gastric scintigraphy. METHODS: The study population comprised patients who had been diagnosed with episodic migraine, according to the International Classification of Headache Disorders, edition II. The entire study population was completely free of gastrointestinal symptoms during the headache-free period. Gastric scintigraphy was performed to determine the time to half emptying (T 1/2) and the percentage of radioactive material remaining in the stomach (%RMR) at 30, 60, 90, and 120 min. RESULTS: Twenty-six migraine patients and 12 normal controls were recruited. The mean T 1/2 did not differ between the two groups (101.8 vs 95.2 min; p=0.432). The %RMR values in the stomach at 30, 60, 90, and 120 min also did not differ significantly between the two groups [87.5% vs 88% (p=0.900), 70.8% vs 71.2% (p=0.950), 54.2% vs 53.3% (p=0.753), and 39.0% vs 37.3% (p=0.583), respectively]. CONCLUSIONS: There is no gastric stasis in patients with episodic migraine during headache-free periods. Our results suggest that the main mechanism underlying the nausea and vomiting in migraine patients is not a gastric stasis in interictal periods, but rather a central process, as a result of changes occurring in the brainstem during acute migraine attacks.
Brain Stem
;
Gastric Emptying
;
Gastroparesis
;
Headache Disorders
;
Humans
;
Migraine Disorders
;
Nausea
;
Stomach
;
Vomiting
7.Relationship between Personality and Insomnia in Panic Disorder Patients.
Hae Ran NA ; Eun Ho KANG ; Bum Hee YU ; Jong Min WOO ; Youl Ri KIM ; Seung Hwan LEE ; Eui Jung KIM ; Sang Yeol LEE ; Sang Keun CHUNG
Psychiatry Investigation 2011;8(2):102-106
OBJECTIVE: Panic disorder (PD) is frequently comorbid with insomnia, which could exacerbate panic symptoms and contribute to PD relapse. Research has suggested that characteristics are implicated in both PD and insomnia. However, there are no reports examining whether temperament and character affect insomnia in PD. Thus, we examined the relationship between insomnia and personality characteristics in PD patients. METHODS: Participants were 101 patients, recruited from 6 university hospitals in Korea, who met the DSM-IV-TR criteria for PD. We assessed sleep outcomes using the sleep items of 17-item Hamilton Depression Rating Scale (HAMD-17)(item 4=onset latency, item 5=middle awakening, and item 6=early awakening) and used the Cloninger's Temperament and Character Inventory-Revised-Short to assess personality characteristics. To examine the relationship between personality and insomnia, we used analysis of variance with age, sex, and severity of depression (total HAMD scores minus sum of the three sleep items) as the covariates. RESULTS: There were no statistical differences (p>0.1) in demographic and clinical data between patients with and without insomnia. Initial insomnia (delayed sleep onset) correlated to a high score on the temperamental dimension of novelty seeking 3 (NS3)(F1,96=6.93, p=0.03). There were no statistical differences (p>0.1) in NS3 between patients with and without middle or terminal insomnia. CONCLUSION: The present study suggests that higher NS3 is related to the development of initial insomnia in PD and that temperament and character should be considered when assessing sleep problems in PD patients.
Depression
;
Hospitals, University
;
Humans
;
Korea
;
Panic
;
Panic Disorder
;
Recurrence
;
Sleep Initiation and Maintenance Disorders
;
Temperament
8.The Effectiveness of 6-Month Treatment with Venlafaxine Extended Release in Generalized Anxiety Disorder: Prospective, Multi-Center, Open-Labeled Trial.
Joo Eon PARK ; Jeong Ho CHAE ; Seung Hwan LEE ; Sung Gon RYU ; Chan Hyung KIM ; Kang Seob OH ; Youl Ri KIM ; Bum Hee YU
Korean Journal of Psychopharmacology 2006;17(1):50-59
OBJECTIVE: We aimed to examine the efficacy and the safety of venlafaxine extended release (venlafaxine-XR), and its effect on the quality of life in patients with generalized anxiety disorder. METHODS: Fifty three patients who had generalized anxiety disorder were recruited for this study. They showed scores of 18 or higher on the Hamilton Rating Scale for Anxiety (HAMA) and did not have major depression. They were scheduled to be examined 5 times (at baseline, 4, 8, 16 and 24 weeks) and took venlafaxine-XR for 24 weeks with a flexible dosing schedule. The primary efficacy variables were the response and remission rates (response: more than 50% reduction from baseline in HAMA total score ; remission: HAMA total score< or =7). Other variables were the Hamilton Ratng Scale for Depression, Beck Anxiety Inventory, Sheehan Disabilities Scale (SDS), and World Health Organization Quality of Life Assessment Instrument-Brief Form (WHOQOL-BREF). Also, the evaluation on adverse effects was performed. RESULTS: The number of patients who completed 24 weeks of treatment was 32 (60.4%). Twenty one patients who were dropped out included 8 patients with intolerable adverse effects and 7 patients with unsatisfactory treatment response. Response/remission rates were 43.4/32.1% in the last-observation-carried-forward methods and 71.9/53.1% in the observed case data. Treatment with venlafaxine-XR improved anxiety and depressive symptoms during 24 weeks on all efficacy measures. By a completed patient analysis, venlafaxine-XR also significantly improved the disability scores on SDS and the quality of life scores on WHOQOL-BREF. In this study, nausea, palpitation, and severe tremor were common reasons of venlafaxine-XR discontinuation in GAD patients, but any serious adverse effect did not occur. CONCLUSION: Treatment with venlafaxine-XR was effective and well-tolerated for the patients with GAD, and also improved quality of life in the GAD patients.
Anxiety Disorders*
;
Anxiety*
;
Appointments and Schedules
;
Depression
;
Humans
;
Nausea
;
Prospective Studies*
;
Quality of Life
;
Treatment Outcome
;
Tremor
;
World Health Organization
;
Venlafaxine Hydrochloride
9.A Case of Systemic Lupus Erythematosus Presenting with Acute Pancreatitis.
Yu ri CHOI ; Chan Hee LEE ; Ea Wha KANG ; Min Seob CHA ; Ha na KIM ; Jeong Hye KIE ; Su mi PARK
The Journal of the Korean Rheumatism Association 2010;17(2):211-215
Systemic lupus erythematosus (SLE) is a multisystem inflammatory disorder mediated by autoantibodies and immune complexes that exhibit a range of symptoms. Although thirty-five to forty percent of patients with SLE show signs or symptoms of gastrointestinal involvement, acute pancreatitis is an uncommon complication of SLE, and SLE presenting with acute pancreatitis is extremely rare. We report a case of a 28-year-old female SLE patient who initially presented with acute abdominal pain and elevated pancreatic enzyme levels. The patient was diagnosed clinically with acute pancreatitis and then with SLE after further investigations. Her condition improved after high dose steroid therapy.
Abdominal Pain
;
Adult
;
Antigen-Antibody Complex
;
Autoantibodies
;
Female
;
Humans
;
Lupus Erythematosus, Systemic
;
Pancreatitis
10.Multiple Myeloma Mimics Bone Metastasis From a Rectal Adenocarcinoma.
Im Kyung KIM ; Jeonghyun KANG ; Yu Ri KIM ; Tae Joo JEON ; Seung Hyuk BAIK ; Seung Kook SOHN
Annals of Coloproctology 2017;33(2):70-73
A presumptive diagnosis of bone metastasis can be easily made when a patient with a history of colorectal cancer develops bone lesions that are seen on follow-up imaging. In this case report, we describe a patient whose multiple bone lesions were wrongly attributed to a recurrence of rectal cancer rather than being identified as multiple myeloma lesions. When clinicians detect new, abnormal, bony lesions in a patient with a previous history of cancer, they should consider diseases such as multiple myeloma in their differential diagnosis.
Adenocarcinoma*
;
Colorectal Neoplasms
;
Diagnosis
;
Diagnosis, Differential
;
Follow-Up Studies
;
Humans
;
Multiple Myeloma*
;
Neoplasm Metastasis*
;
Rectal Neoplasms
;
Recurrence